Last €16.33 EUR
Change Today +0.17 / 1.05%
Volume 1.1K
GDS On Other Exchanges
EN Paris
As of 11:35 AM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

generale de sante (GDS) Snapshot

Previous Close
Day High
Day Low
52 Week High
06/3/14 - €17.55
52 Week Low
12/20/13 - €12.00
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for GENERALE DE SANTE (GDS)

Related News

No related news articles were found.

generale de sante (GDS) Related Businessweek News

No Related Businessweek News Found

generale de sante (GDS) Details

Générale de Santé Société Anonyme operates a network of private hospitals and clinics. The company’s hospitals and clinics offer a range of services in the areas of medicine, surgery, obstetrics, psychiatry, alcoholism, obesity and cancer treatments, and radiation therapy. It also provides rehabilitation care, diagnostics imaging, and medical analyses, as well as home-based care services. The company offers its services in 112 locations, including 110 locations in France, as well as in Italy and Switzerland. Générale de Santé Société Anonyme is based in Paris, France.

19,000 Employees
Last Reported Date: 07/31/14

generale de sante (GDS) Top Compensated Officers

Chief Executive Officer
Total Annual Compensation: €776.3K
Deputy Chief Executive Officer, Managing Dire...
Total Annual Compensation: €615.3K
Compensation as of Fiscal Year 2012.

generale de sante (GDS) Key Developments

Générale de Santé Announces Earnings Results for the First Half Year Ended June 30, 2014

Générale de Santé announced earnings results for the first half year ended June 30, 2014. For the period, the company reported EBITDAR of EUR 197 million compared to EUR 218 million a year ago. EBIT was EUR 68 million compared to EUR 67 million a year ago.

Générale de Santé Société Anonyme, H1 2014 Earnings Call, Jul 31, 2014

Générale de Santé Société Anonyme, H1 2014 Earnings Call, Jul 31, 2014

Générale de Santé Reports Consolidated and Company Earnings Results for the First Half Ended June 2014

Générale de Santé reported consolidated and company earnings results for the first half ended June 2014. For the period, on company basis, the company reported revenue of EUR 882.8 million against EUR 982.1 million a year ago. EBITDA was EUR 126.0 million against EUR 137.8 million a year ago. Current operating profit was EUR 71.7 million against EUR 76.5 million a year ago. Operating profit was EUR 67.8 million against EUR 66.7 million a year ago. Net income attributable to the Group was EUR 27.4 million or EUR 0.49 per share diluted against EUR 26.8 million or EUR 0.47 per share diluted a year ago. Net profit for the period was EUR 30.8 million against EUR 30.3 million for the same period last year. Net cash from operating activities were EUR 62.0 million against EUR 74.6 million for the same period last year. Purchase of property, plant & equipment and intangible assets was EUR 33.2 million against EUR 46.3 million a year ago. The seasonal increase in net financial debt per IFRS was EUR 627.4 million at end of June 2014, down compared with June 2013 of EUR 810.4 million.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GDS:FP €16.33 EUR +0.17

GDS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Korian-Medica €29.84 EUR +0.73
View Industry Companies

Industry Analysis


Industry Average

Valuation GDS Industry Range
Price/Earnings 7.6x
Price/Sales 0.5x
Price/Book 1.9x
Price/Cash Flow 3.8x
TEV/Sales 0.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GENERALE DE SANTE, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at